Staphylococcus aureus is an important human pathogen .It is one of the common of both endemic and epidemic infections acquired in hospitals which result in substantial morbidity and mortality. S.aureus causing 50% or more of hospital-acquired S.aureus infections in several countries andcould cause life-threatening infections when mucosal or cutaneous barriers are broken.This study aims to determine the Erythromycin and inducible Clindamycin phenotypic and genotypic resistance, and the estimation prevalence of Erm A gene among the identified S.aureus in Maysan Province . A total of 300 samples were taken from patients suffering from different clinical infections during a period continued from October 2018 till March 2019 .The samples were routinely cultivated and confirmed by using standard laboratory techniques where (103) were identified as S.aurues. The results of Erythromycin resistance and Clindamycin were 62 (60.1%) and 41 (39.8%) respectively. While the result of D-test appeared that 12 (11.6%) were positive to D-test whilst resistance to both Erythromycin and Clindamycin (R phenotype) was 15(14.5%)and sensitivity to both Erythromycin and Clindamycin (S phenotype) was 23 (22.5%). The result of Polymerase Chain Reaction (PCR) revealed that 100 (97%) of S.aureus were carried the ErmA gene .So the study went to concluded the high rates of prevalence of Erm A gene among identified S.aureus as comparing with phenotypic results which in turn lead to reduce the chance of available treatment especially through the intensive care units.
Cite this article:
Amany Menam Mtsher, Zahid Saadoon Aziz. Estimation of Erythromycin and inducible Clindamycin Resistance in Saphylococcus aureus Isolated from Clinical Cases. Research J. Pharm. and Tech 2020; 13(6): 2920-2924. doi: 10.5958/0974-360X.2020.00538.7
1. Weber, D. J., Rutala, W. A., Miller, M. B., Huslage, K., and Sickbert-Bennett, E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. American Journal of Infection Control. 2010; 38(5): S25-S33.
2. Uhlemann, A. C., Otto, M., Lowy, F. D., and DeLeo, F. R. Evolution of community-and healthcare-associated methicillin-resistant Staphylococcus aureus. Infection, Genetics and Evolution. 2014; (21): 563-574.
3. Köck, R., Becker, K., Cookson, B., van Gemert-Pijnen, J. E., Harbarth, S., Kluytmans, J. A. J. W., and Tacconelli, E. Methicillin-resistant Staphylococcus aureus(MRSA): burden of disease and control challenges in Europe. Review article, Euro Surveill .2010; 15 (42) pii:19694.
4. Yan, X., Schouls, L. M., Pluister, G. N., Tao, X., Yu, X., Yin, J., and He, L. The population structure of Staphylococcus aureus in China and Europe assessed by multiple-locus variable number tandem repeat analysis; clues to geographical origins of emergence and dissemination. Clinical Microbiology and Infection .2016; 22(1): 60-e1.
5. Avci, P., Sadasivam, M., Gupta, A., De Melo, W. C., Huang, Y. Y., Yin, R., and Hamblin, M. R. Animal models of skin disease for drug discovery. Expert Opinion on Drug Discovery. 2013; 8(3): 331-355.
6. Ahmad, S. Antibiotics in chronic suppurative otitis media: A bacteriologic study. Egyptian Journal of Ear, Nose, Throat and Allied Sciences. 2013;14(3): 191-194.
7. Fasih, N., Irfan, S., Zafar, A., Khan, E., andHasan, R. Inducible clindamycin resistance due to expression of erm genes in Staphylococcus aureus: report from a tertiary care hospital Karachi, Pakistan. Journal of the Pakistan Medical Association. 2010; 60(9): 750.
8. Tarai , B., Das, P., and Kumar, D. Recurrent challenges for clinicians: emergence of methicillin-resistant Staphylococcus aureus, vancomycin resistance, and current treatment options. Journal of Laboratory Physicians .2013; 5(2): 71.
9. Cetin, E. S., Gunes, H., Kaya, S., Aridogan, B. C., and Demirci, M.. Distribution of genes encoding resistance to macrolides, lincosamides and streptogramins among clinical staphylococcal isolates in a Turkish university hospital. Journal of Microbiology, Immunology and Infection. 2010;43(6): 524-529.
10. Sathish, J. V., and Janakiram, K. Inducible clindamycin resist S.aureus: Reason for treatment. Journal of International Medicine and Dentistry. 2015; 2(2): 97-103.
11. Clinical and Laboratory Standard Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M100-27thed. 2017; Wayne, PA,USA.
12. Strommenger B., Kettlitz C., Werner G and Witter W. Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance gene in Staphylococcus aureus .Journal of clinical Microbiology. 2003; 41,4089-4094.
13. Zehra .A.,singh R .,Kaur S and Gill J. P.S.Molecular characterization of antibiotic -resistance Staphylococcus aureus from livestock (Bovine and Swine). Veterinary world .2017; 10(6):598-604.
14. Mishra,A.K.,Yadav,P.A Systemic Review on staphylococcal Scalded skin Syndrome (SSSS):A rare and Critical Disease of Neonates .Open Microbial J .2016; 10:150-159.
15. Palavecino, E. L. Clinical, epidemiologic, and laboratory aspects of methicillin-resistant Staphylococcus aureus infections. In Methicillin-resistant Staphylococcus aureus (MRSA) protocols (pp. 1-24).2014; Humana Press, Totowa, NJ.
16. Patil, N. R., Mali, U. S., Kulkarni, S. A., Ghorpadeand, M. V., and Mane, V. Detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a tertiary care hospital. Int. J. Curr. Microbiol. App. Sci .2014;3 (9), 689-694.
17. Oguzkaya-Artan, M.; Baykan, Z. and Artan, C. "Nasal carriage of Staphylococcus aureus in healthy preschool Children ".J. Pn. Infect. Dis., .2008; 61 (1): 70 -72.
18. Jayavanth. P "Ceftazidime and Vancomycine Sensitive Beta Hemolytic Staphylococcus aureus" .2011 ; I.J.P.B.R .2(2):63-66.
19. Al-Dulimi, A. M .N. "Identification of Methicillin Resistance Staphylococcus aureus (MRSA) from Clinical Samples Using PCR Techinque and Detection of Its Susceptibility to Ceftaroline and other Antibiotics" M.SC Thesis. College of Science for Women .2015; University of Baghdad.pp.1-121.
20. Al-baidani, A.R. H.; Elshouny, W.A. and Shawa, T.M. "Antibiotic susceptibility pattern of methicillin resistant Staphylococcus aureus in three hospitals at hodeidah city, yamen " Gl .J . Pharma .2011; 5(2): 106-111.
21. Alalem, M.A "Antibiotic resistance Staphylococcus aureus Infection studies in hospitals" Ph.D Thesis. Middle East Technical University. 2008 ;p73-74.
22. Khorvash, F.; Abdi, F. and Ataei, B. "Nasal carriage of Staphylococcus aureus: Frequency and antibiotic resistance in healthy adults " J. Res. Med. Sci., Special Issue .2012; (2):S229-S232.
23. Prabhu, K.,Rao, S., and Rao, V.Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. Journal of Laboratory Physicians. 2011; 3 (1) :25.
24. Gardiner, B. J., Grayson, M. L., and Wood, G. M. Inducible resistance to clindamycin in Staphylococcus aureus: validation of Vitek-2 against CLSI D-test. Pathology. 2013; 45(2): 181-184.
25. Fasih, N., Irfan, S., Zafar, A., Khan, E., andHasan, R.. Inducible clindamycin resistance due to expression of erm genes in Staphylococcus aureus: report from a tertiary care hospital Karachi, Pakistan. Journal of the Pakistan Medical Association. 2010; 60(9): 750.
26. Haznedaroğlu, T., Kural, M., Baylan, O., Özyurt, M., andArdıç, N. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of coagulase negative staphylococci and Staphylococcus aureus. Tıp Araştırmaları Dergisi .2011; 9(2): 120-127.
27. Steward, C. D., Raney, P. M., Morrell, A. K., Williams, P. P., McDougal, L. K., Jevitt, L., and Tenover, F. C. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. Journal of Clinical Microbiology .2005 ; 43(4): 1716-1721. 14.
28. Grace,F. M.D-Test for Detection of Antimicrobial Susceptibility in Methicillin Resistant Staphylococcus aureus (MRSA) (IOSR-JPBS) e-ISSN: 2278-3008, p-ISSN:2319-7676. 2013; Volume 7, Issue 3. PP 32-35 .
29. Vivek, J. S., Rajesh, G. N., Mukesh, S., Manpreet, K., Saikat, B., and Ajay, K. Prevalence of inducible Clindamycin resistance among community-and hospital-associated Staphylococcus aureus isolates in a tertiary care hospital in India .2011; Volume 22, Issue 4
30. Bhargava, K., and Zhang, Y.. Multidrug‐resistant coagulase‐negative Staphylococci in food animals. Journal of Applied Microbiology. 2012;113(5): 1027-1036.
31. Ansari, S., Nepal, H. P., Gautam, R., Rayamajhi, N., Shrestha, S., Upadhyay, G., and Chapagain, M. L. Threat of drug resistant Staphylococcus aureus to health in Nepal. BMC Infectious Diseases . 2014; 14(1): 157.
32. Dehkordi, F. S., Gandomi, H., Basti, A. A., Misaghi, A., andRahimi, E. Phenotypic and genotypic characterization of antibiotic resistance of methicillin-resistant Staphylococcus aureus isolated from hospital food. Antimicrobial Resistance and Infection Control .2017; 6(1): 104.
33. Zmantar, T., Kouidhi, B., Miladi, H., andBakhrouf, A. Detection of macrolide and disinfectant resistance genes in clinical Staphylococcus aureus and coagulase-negative staphylococci. BMC Research Notes .2011;4(1): 453.